Drug Purity Report Week 34, 2026

Drug Purity Report: Week 34, 2026

Drug Purity Report #34/26. In this week’s report on drug market purity we are shining spotlight on fake hash, extreme MDMA pills and more PMMA.

Data fatigue is real, so here we come to give you the gist of what’s going on out there. For more details, photos, and other information on thousands of drugs, head out straight to the DrugsPRO app.

  1. A fake hash sample found in Zurich contained 2 different synthetic cannabinoids: MDMB-4en-PINACA and ADB-4en-PINACA. We remind all cannabis users that with the current availability of CBD, the financial incentive is much higher to sell synthetic cannabinoids than real classic THC products.
  2. Pills closing in on almost 300 mg of MDMA detected in Spain’s Tarragona and in Basel, Switzerland. The first is a gray Grim Reaper with “350mg” stamped (283 mg MDMA detected), and the other an orange Master Roshi (260 mg MDMA).
  3. Although PMMA was not detected this particular week, due to more samples detected in the recent days we are repeating the warning. PMMA has been found in multiple samples this year. It has hardly any expected effects of MDMA, while having plenty of the undesired effects. Using a test kit is essential to reduce the risk of PMMA poisoning.

Last Week at a Glance

  • 57 samples from 5 countries (Austria, France, Slovenia, Spain and Switzerland) were included this week.
  • 48 samples contained a quantified result, including 10 pills and 3 LSD samples.
  • 13 samples contained more than one detected ingredient.
  • LSD median purity/content is 230µg, compared with 70µg in the yearly reference period.

Key Purity Differences

  • LSD median purity/content is 230µg, compared with 70µg in the yearly reference period.
  • MDMA median purity/content is 178mg, compared with 160mg in the yearly reference period.
  • Mephedrone median purity/content is 79%, compared with 88% in the yearly reference period.

Purity and Content

Median quantified results for 17–23 August 2026. The yearly reference is shown in parentheses where sufficient comparison data is available.

SamplesSubstanceTypical purity / content
9MDMA178mg (160mg*)
Middle 50%: 143–198mg
6Cocaine94% (86%*)
Middle 50%: 83–96.8%
3Ketamine100% (94%*)
Middle 50%: 90.5–100%
3LSD230µg (70µg*)
Middle 50%: 216.5–253.5µg
3Mephedrone79% (88%*)
Middle 50%: 40.5–89.5%

How to read this: Bold = this week’s median (typical) result; “Middle 50%” = half of the results; (*) = median from the last 365 days; ▲/▼ = higher/lower than last week.

Most Common Adulterants and Other Impurities

Across the last 365 days, 1,926 mixed samples contained 139 distinct additional ingredients.

SamplesAdditional ingredientShare of substance mixturesMost often found with
675Caffeine83.2%
of amphetamine samples
Amphetamine, Heroin, MDMA
264Unknown25.4%
of MDMA samples
MDMA, Mephedrone, 2C substances
159Paracetamol81.7%
of heroin samples
Heroin, Cocaine, Ketamine
114iso-LSD95%
of LSD samples
LSD
112MDMA44.9%
of ketamine samples
Ketamine, 2C substances, Mephedrone
1054-CMC36.9%
of mephedrone samples
Mephedrone, MDMA, Ketamine
100Ketamine18.5%
of MDMA samples
MDMA, Amphetamine, Cocaine
96Procaine32.5%
of cocaine samples
Cocaine, Ketamine, MDMA
632-MMC14.4%
of mephedrone samples
Mephedrone, MDMA, Ketamine
63Phenacetin16.4%
of cocaine samples
Cocaine, Heroin, Ketamine
58Levamisole20.4%
of cocaine samples
Cocaine, Ketamine
44Cocaine13%
of ketamine samples
Ketamine, Heroin, Amphetamine
43Amphetamine5.7%
of MDMA samples
MDMA, Ketamine, Cocaine
384-BEC20.3%
of mephedrone samples
Mephedrone
372C-B9%
of MDMA samples
MDMA, Ketamine, Amphetamine
334-MMC6.3%
of MDMA samples
MDMA, Ketamine, Cocaine
33DPIA7.5%
of amphetamine samples
Amphetamine
291-PEA6.4%
of amphetamine samples
Amphetamine, MDMA
27d-8-Tetrahydrocannabinol31.8%
of THC samples
THC/cannabinoids
22NEP6.4%
of mephedrone samples
Mephedrone, MDMA, Ketamine

▲/▼ shows whether its share in the rolling 365-day data increased or decreased since last week. No arrow means no change or no comparison.

Impurities Detected This Week

MDMA: 2-MMC (1), 4-MMC (1)

Cocaine: Phenacetin (1), Procaine (1)

Ketamine: 2-MMC (1)

LSD: iso-LSD (2)

THC/cannabinoids: ADB-4en-PINACA (1), Freies Cbd (1), MDMB-4en-PINACA (1)

Mephedrone: 4-CMC (1), MDMA (1), Unknown (1)

Remaining detected substances: 2-MMC (7), 3-CMC (2), 4-CMC (8), 4-HO-MET (1), GBL (1), NEP (5), Paracetamol (1), Unknown (3)

Data Sources

This report is based on drug-checking data published by: (Bern, (Lausanne) École des sciences criminelles (ESC), (Luzern, (Zürich) Reseachem GmbH, addiction-neuchatel.ch, ailaket.com, Basel) IRM Basel, Biel) Pharmazeutischen Kontrolllabor Bern, checkit.wien, contact-suchthilfe.ch, DIZ / Saferparty, drogart.org, drogenarbeitz6.at, drugchecking.berlin, drugchecking.ch, druglab.fr, energycontrol.org, knowyourstuff.nz, neutravel.net, nightlifevaud.ch, nuit-blanche.ch, raveitsafe.ch, saferdancebasel.ch, saferparty.ch, stoftest.org, tragwerk-luzern.ch, Trimbos, Trimbos NL, triptalks.at, Université Lausanne, wedinos.wales.

All of this data is available at your fingertips in the DrugsPRO app for Android, iOS, and the web.

Drug-checking results describe tested samples only and are not representative of the entire market.

DrugsPRO App

Journaling & Drug Checking

Private journaling, guided test interpretation, lab alerts and reference tools in one offline-first app. Your data stays on your device.

No test result can tell you a substance is safe. No substance is 100% safe.This article is published for harm reduction purposes. It does not encourage the use of psychoactive substances and does not replace medical advice.